AMNEAL PHARMS NY FDA Approval ANDA 077289

ANDA 077289

AMNEAL PHARMS NY

FDA Drug Application

Application #077289

Application Sponsors

ANDA 077289AMNEAL PHARMS NY

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET;ORALEQ 10MG BASE0CITALOPRAM HYDROBROMIDECITALOPRAM HYDROBROMIDE
002TABLET;ORALEQ 20MG BASE0CITALOPRAM HYDROBROMIDECITALOPRAM HYDROBROMIDE
003TABLET;ORALEQ 40MG BASE0CITALOPRAM HYDROBROMIDECITALOPRAM HYDROBROMIDE

FDA Submissions

ORIG1AP2006-11-30
LABELING; LabelingSUPPL3AP2008-04-03
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2011-01-13
LABELING; LabelingSUPPL8AP2012-04-25
LABELING; LabelingSUPPL15AP2014-11-03STANDARD
LABELING; LabelingSUPPL18AP2014-11-03STANDARD
LABELING; LabelingSUPPL19AP2014-11-03STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL8Null15
SUPPL15Null7
SUPPL18Null7
SUPPL19Null7

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

AMNEAL PHARMS NY
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 77289
            [companyName] => AMNEAL PHARMS NY
            [docInserts] => ["",""]
            [products] => [{"drugName":"CITALOPRAM HYDROBROMIDE","activeIngredients":"CITALOPRAM HYDROBROMIDE","strength":"EQ 10MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"CITALOPRAM HYDROBROMIDE","activeIngredients":"CITALOPRAM HYDROBROMIDE","strength":"EQ 20MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"CITALOPRAM HYDROBROMIDE","activeIngredients":"CITALOPRAM HYDROBROMIDE","strength":"EQ 40MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CITALOPRAM HYDROBROMIDE","submission":"CITALOPRAM HYDROBROMIDE","actionType":"EQ 10MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"CITALOPRAM HYDROBROMIDE","submission":"CITALOPRAM HYDROBROMIDE","actionType":"EQ 20MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"CITALOPRAM HYDROBROMIDE","submission":"CITALOPRAM HYDROBROMIDE","actionType":"EQ 40MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.